Global X Scientific Beta Europe ETF
SCID
SCID was delisted on the 21st of August, 2020.
7 hedge funds and large institutions have $1.41M invested in Global X Scientific Beta Europe ETF in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
25% less capital invested
Capital invested by funds: $1.89M → $1.41M (-$473K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$742K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.53K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$84 |
SCID Hedge Fund Activity: Q2 2020 in Review
7 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Global X Scientific Beta Europe ETF (SCID) for Q2 2020, worth a combined $1.41M — down 25% from $1.89M a quarter earlier.
Fund positioning in SCID was balanced in Q2 2020: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $2.08K. The largest seller was Susquehanna International Group, cutting an estimated $742K.
- 7 institutional investors held Global X Scientific Beta Europe ETF (SCID) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $1.41M of Global X Scientific Beta Europe ETF stock for Q2 2020, down 25% quarter-over-quarter.
- 0 funds opened new Global X Scientific Beta Europe ETF positions in Q2 2020 and 0 closed out.
- The largest Global X Scientific Beta Europe ETF buyer in Q2 2020 was Royal Bank of Canada, an estimated $2.08K added.
- The largest Global X Scientific Beta Europe ETF seller in Q2 2020 was Susquehanna International Group, an estimated $742K sold.
Based on aggregated 13F filings for Q2 2020.